MedTrace Logo

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

NCT00985361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2010-05-06

No results posted yet for this study

Summary

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 2000 international units daily

Vitamin D3 2000 international unit tablets once daily for 3 months

DIETARY_SUPPLEMENT

Vitamin C 500mg daily

Vitamin C 500mg tablets once daily for 3 months

Sponsors & Collaborators

  • ProMedica Health System

    lead OTHER

Principal Investigators

  • Mate M Soric, PharmD · ProMedica Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985361 on ClinicalTrials.gov